ADVIA 2120i with DAA Autosampler
Device DX - Diagnostics incl. all products and services
PDI 00630414019772
General payments
$2,581
Research payments
$164,334
Through program year 2025, $2,581 in general payments and $164,334 in research payments were reported against ADVIA 2120i with DAA Autosampler (DX - Diagnostics incl. all products and services).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $14 | 1 |
| 2024 | General | $897 | 6 |
| 2024 | Research | $140,796 | 3 |
| 2022 | General | $1,670 | 1 |
| 2021 | Research | $23,537 | 5 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
8 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.